Olivier Jordan
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 22
- Electrospun Nanofibers in Biomedical Applications 9
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 11
- Molecular Medicine top 1%
- Rehabilitation top 1%
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms 20
-
- Intracranial Aneurysms: Treatment and Complications 8
-
- Proteoglycans and glycosaminoglycans research 8
-
- Inflammatory mediators and NSAID effects 7
-
- Tendon Structure and Treatment 7
- Co-authors
- Gerrit BorchardÉric AllémannViorica PatruleaÉric DoelkerVasile OstafePierre MaudensRobert GurnyChristian A. Seemayer
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)ACS Nano (1 paper)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
Olivier Jordan
117 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Biomaterials 1.4k
- Pharmaceutical Science 531
- Molecular Medicine 351
- Rehabilitation 369
- Rheumatology 669
Countries citing papers authored by Olivier Jordan
This map shows the geographic impact of Olivier Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Jordan more than expected).
Fields of papers citing papers by Olivier Jordan
This network shows the impact of papers produced by Olivier Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Jordan. The network helps show where Olivier Jordan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier Jordan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 16 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 13 | |
| 10 | 2021 | 105 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 24 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 34 | |
| 15 | 2017 | 55 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 22 | |
| 18 | 2012 | 23 | |
| 19 | 2007 | 139 | |
| 20 | 2005 | 36 |
About Olivier Jordan
Olivier Jordan is a scholar working on Biomaterials, Pharmaceutical Science and Rheumatology, having authored 119 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (22 papers), Osteoarthritis Treatment and Mechanisms (20 papers), Advanced Drug Delivery Systems (11 papers), Electrospun Nanofibers in Biomedical Applications (9 papers), Intracranial Aneurysms: Treatment and Complications (8 papers), Proteoglycans and glycosaminoglycans research (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Tendon Structure and Treatment (7 papers). The work is most often cited by research in Biomaterials (1.4k citations), Pharmaceutical Science (531 citations) and Molecular Medicine (351 citations). Olivier Jordan has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include Gerrit Borchard, Éric Allémann, Viorica Patrulea, Éric Doelker, Vasile Ostafe, Pierre Maudens, Robert Gurny, Christian A. Seemayer, Alban Denys and Heinrich Hofmann. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.